Market Overview:
The global enteric softgel capsules market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for softgel capsules as an alternative to hard gelatin capsules and tablets, rising prevalence of lifestyle diseases, and growing demand for nutraceuticals and functional foods. Based on type, the global enteric softgel capsules market can be segmented into gelatin type and vegetable type. The gelatin type segment is expected to account for a larger share of the market in 2018 owing to its superior properties such as high tensile strength, water resistance, and compatibility with a wide range of ingredients.
Product Definition:
Enteric softgel capsules are designed to protect the ingredients from being broken down by stomach acids. This allows the ingredients to be released in the small intestine, where they can be absorbed into the bloodstream. Enteric softgel capsules are used to deliver medications that would otherwise be destroyed by stomach acids, such as certain types of antibiotics and drugs used to treat heartburn or ulcers.
Gelatin Type:
Gelatin is a protein that occurs in the connective tissues of animals and plants. It has been used as an ingredient in pharmaceutical formulations for over two centuries. Gelatin is extracted from animal sources such as bovine, porcine, poultry, and marine; whereas plant-derived gelatin can be obtained from beef bones or seaweed extracts.
Vegetable Type:
The vegetable type is a group of plants that grow underground and above-ground parts of the same plant are used to produce vegetable type enteric softgel capsules. The most commonly used vegetables for producing these capsules include amaranth, artichoke, asparagus, beets, broccoli rabe (Brassica juncea), cabbage leafy greens like kale and chard among others.
Application Insights:
The others application segment accounted for the largest revenue share in 2017. The antibiotic and antibacterial drugs application segment is expected to grow at a significant rate over the forecast period owing to increasing prevalence of infectious diseases, especially among children. Furthermore, rising incidences of chronic diseases are anticipated to boost demand for enteric softgel capsules as they provide easy digestion and reduce gas formation by acting as antacids.
Antacid and antiflatulent preparations are also expected to witness lucrative growth during the forecast period due largely on account of their high consumption in Asia Pacific region. In addition, growing awareness regarding digestive comfort along with an increase in spending capacity is anticipated fuel demand for antacid drugs particularly among high-income class consumers across North America and Europe regions over the next eight years.
Regional Analysis:
Asia Pacific dominated the global enteric softgel capsules market in 2017. The region is expected to maintain its position during the forecast period owing to increasing product consumption for treatment of acid reflux and ulcers, bacterial infections, and as an antibiotic. In addition, rising geriatric population prone to various diseases is anticipated to fuel demand for anti-diarrheal drugs in this region.
The Asia Pacific market was valued at USD X billion in 2017 and is projected to grow at a significant rate over the forecast period due to high unmet medical needs coupled with rapidly growing healthcare expenditure levels in emerging economies such as China & India. Increasing investments by major pharmaceutical companies are also contributing towards growth of this regional market on account of rising awareness regarding benefits of these products over conventional tablets & capsules (mainly due their ease in administration).
Europe accounted for a significant share followed by North America owing mainlyto higher adoption rates observedin countries like Germany, U.K.
Growth Factors:
- Increasing demand for convenience foods: The growing trend of busy lifestyles has led to an increase in the demand for convenient food options such as enteric softgel capsules. These capsules offer a quick and easy way to consume essential nutrients without having to chew or swallow large tablets.
- Rising awareness about the health benefits of softgels: There is a growing awareness among consumers about the health benefits of taking supplements in the form of softgels. This is driving demand for enteric softgel capsules, which are seen as a more efficient and effective way to take supplements than traditional tablets or capsules.
- Growing popularity of natural ingredients: A growing number of consumers are opting for natural ingredients over synthetic ones, due to concerns about the potential side effects of synthetic ingredients. Enteric softgel capsules made with natural ingredients are therefore seeing increasing demand from consumers looking for safe and healthy dietary supplements.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enteric Softgel Capsules Market Research Report
By Type
Gelatin Type, Vegetable Type
By Application
Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others
By Companies
Catalent, Sirio Pharma, Aenova, ProCaps, InovoBiologic, Alpha, Dart Neuroscience, BASF, Lonza, NutraNorth
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Enteric Softgel Capsules Market Report Segments:
The global Enteric Softgel Capsules market is segmented on the basis of:
Types
Gelatin Type, Vegetable Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Catalent
- Sirio Pharma
- Aenova
- ProCaps
- InovoBiologic
- Alpha
- Dart Neuroscience
- BASF
- Lonza
- NutraNorth
Highlights of The Enteric Softgel Capsules Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gelatin Type
- Vegetable Type
- By Application:
- Antacid and Antiflatulent Preparations
- Antibiotic and Antibacterial Drugs
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enteric Softgel Capsules Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enteric softgel capsules are a type of medication that are taken by mouth. They are made from a gel or liquid form of the drug and they come in small, easy-to-swallow capsules. Enteric softgel capsules work by slowly releasing the drug over time into the stomach and intestines. This allows for better absorption of the drug into the body than if it were taken as a pill or tablet.
Some of the key players operating in the enteric softgel capsules market are Catalent, Sirio Pharma, Aenova, ProCaps, InovoBiologic, Alpha, Dart Neuroscience, BASF, Lonza, NutraNorth.
The enteric softgel capsules market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Enteric Softgel Capsules Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Enteric Softgel Capsules Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Enteric Softgel Capsules Market - Supply Chain
4.5. Global Enteric Softgel Capsules Market Forecast
4.5.1. Enteric Softgel Capsules Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Enteric Softgel Capsules Market Size (000 Units) and Y-o-Y Growth
4.5.3. Enteric Softgel Capsules Market Absolute $ Opportunity
5. Global Enteric Softgel Capsules Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Enteric Softgel Capsules Market Size and Volume Forecast by Type
5.3.1. Gelatin Type
5.3.2. Vegetable Type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Enteric Softgel Capsules Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Enteric Softgel Capsules Market Size and Volume Forecast by Application
6.3.1. Antacid and Antiflatulent Preparations
6.3.2. Antibiotic and Antibacterial Drugs
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Enteric Softgel Capsules Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Enteric Softgel Capsules Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Enteric Softgel Capsules Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Enteric Softgel Capsules Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Enteric Softgel Capsules Demand Share Forecast, 2019-2029
9. North America Enteric Softgel Capsules Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Enteric Softgel Capsules Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Enteric Softgel Capsules Market Size and Volume Forecast by Application
9.4.1. Antacid and Antiflatulent Preparations
9.4.2. Antibiotic and Antibacterial Drugs
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Enteric Softgel Capsules Market Size and Volume Forecast by Type
9.7.1. Gelatin Type
9.7.2. Vegetable Type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Enteric Softgel Capsules Demand Share Forecast, 2019-2029
10. Latin America Enteric Softgel Capsules Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Enteric Softgel Capsules Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Enteric Softgel Capsules Market Size and Volume Forecast by Application
10.4.1. Antacid and Antiflatulent Preparations
10.4.2. Antibiotic and Antibacterial Drugs
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Enteric Softgel Capsules Market Size and Volume Forecast by Type
10.7.1. Gelatin Type
10.7.2. Vegetable Type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Enteric Softgel Capsules Demand Share Forecast, 2019-2029
11. Europe Enteric Softgel Capsules Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Enteric Softgel Capsules Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Enteric Softgel Capsules Market Size and Volume Forecast by Application
11.4.1. Antacid and Antiflatulent Preparations
11.4.2. Antibiotic and Antibacterial Drugs
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Enteric Softgel Capsules Market Size and Volume Forecast by Type
11.7.1. Gelatin Type
11.7.2. Vegetable Type
11.8. Basi Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Enteric Softgel Capsules Demand Share, 2019-2029
12. Asia Pacific Enteric Softgel Capsules Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Enteric Softgel Capsules Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Enteric Softgel Capsules Market Size and Volume Forecast by Application
12.4.1. Antacid and Antiflatulent Preparations
12.4.2. Antibiotic and Antibacterial Drugs
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Enteric Softgel Capsules Market Size and Volume Forecast by Type
12.7.1. Gelatin Type
12.7.2. Vegetable Type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Enteric Softgel Capsules Demand Share, 2019-2029
13. Middle East & Africa Enteric Softgel Capsules Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Enteric Softgel Capsules Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Enteric Softgel Capsules Market Size and Volume Forecast by Application
13.4.1. Antacid and Antiflatulent Preparations
13.4.2. Antibiotic and Antibacterial Drugs
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Enteric Softgel Capsules Market Size and Volume Forecast by Type
13.7.1. Gelatin Type
13.7.2. Vegetable Type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Enteric Softgel Capsules Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Enteric Softgel Capsules Market: Market Share Analysis
14.2. Enteric Softgel Capsules Distributors and Customers
14.3. Enteric Softgel Capsules Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Catalent
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sirio Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aenova
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ProCaps
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. InovoBiologic
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Alpha
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dart Neuroscience
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BASF
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lonza
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. NutraNorth
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
